An urokinase receptor antagonist that inhibits cell migration by blocking the formyl peptide receptor.
about
Synthetic Peptides as Protein MimicsSingle amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasionRetro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas.Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence.Cyclization of the urokinase receptor-derived ser-arg-ser-arg-tyr Peptide generates a potent inhibitor of trans-endothelial migration of monocytes.Expression of uPAR in human trophoblast and its role in trophoblast invasion.Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer.The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells.Characteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy.Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells.Preclinical evaluation of the urokinase receptor-derived peptide UPARANT as an anti-inflammatory drug.Treatment with a Urokinase Receptor-derived Cyclized Peptide Improves Experimental Colitis by Preventing Monocyte Recruitment and Macrophage Polarization
P2860
Q26770255-1C9C61B5-00D7-434C-897D-96520846E450Q27319474-A59F68A3-6E17-4202-9BA0-99C9FCB74984Q33683537-C48C67C7-73A2-4454-BA25-9B70C2712691Q34100895-83E2BDF7-9CE0-4079-90D0-532339B8DCE1Q35621562-70FD100F-321C-49ED-8DC9-8BF6ED07F443Q36464417-2C86953F-766D-45B4-809B-CA4CD87D8951Q37432551-EFA5FFF2-4941-45DD-8E2D-A50960F4C26AQ37688084-B2933853-C955-4DDC-8A45-E3DB059BF5A2Q37801943-C9935A05-93CD-4223-8810-DEABDECA285BQ39640346-9B59105F-A0D9-4129-BEFE-DF0E3E11A204Q46433119-306C18CA-FEDA-4DF4-B0A1-7C36E00265F2Q47140492-BAA10F99-14A3-4264-BB39-5A0B2E1FB5EBQ52774062-6441EB88-44EE-4051-A5B6-E128912277BCQ58883590-061B3D5F-F834-48AB-9EDC-8DB57EB5BB43
P2860
An urokinase receptor antagonist that inhibits cell migration by blocking the formyl peptide receptor.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
An urokinase receptor antagoni ...... g the formyl peptide receptor.
@en
type
label
An urokinase receptor antagoni ...... g the formyl peptide receptor.
@en
prefLabel
An urokinase receptor antagoni ...... g the formyl peptide receptor.
@en
P2093
P2860
P1433
P1476
An urokinase receptor antagoni ...... g the formyl peptide receptor.
@en
P2093
Immacolata Longanesi-Cattani
Katia Bifulco
Lucia Gargiulo
Maria Patrizia Stoppelli
Maria Vincenza Carriero
Mario De Rosa
Mauro Cataldi
Ornella Maglio
Vincenzo Pavone
P2860
P304
P356
10.1016/J.FEBSLET.2008.03.001
P407
P577
2008-03-11T00:00:00Z